Streetbeat News

Stock Prices

SLGL

Sol-Gel Technologies (NASDAQ:SLGL) reported Q4 earnings with an EPS of $-0.17, matching estimates, and a revenue increase of $347 thousand from the previous year. Despite meeting EPS estimates, past performance shows a 7% drop in share price following last quarter's earnings beat.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 1:40 pm

INDP

Indaptus Therapeutics (NASDAQ:INDP) reported Q4 earnings, beating estimates with an EPS of $-0.46 against an expected $-0.54. However, revenue remained unchanged from the previous year. Despite beating last quarter's EPS estimates, the share price dropped by 10% the following day.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 1:40 pm

PHUN

HC Wainwright & Co. analyst Scott Buck maintains a Buy rating on Phunware (NASDAQ:PHUN) and adjusts the price target to $12 from $1, accounting for a 1:50 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 1:40 pm

CLNN

Clene (NASDAQ:CLNN) reported Q4 earnings with an EPS of $-0.01, beating estimates by 86.0% against an expected $-0.07. However, revenue decreased by $64 thousand compared to the same period last year. In the previous quarter, Clene also surpassed EPS estimates, which was followed by a 1.0% drop in share price the next day.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 1:40 pm

AAPL

Apple Inc. (NASDAQ:AAPL) is advancing its technology with a revised patent for 'Camera Systems For Bendable Electronic Devices', focusing on integrating multiple cameras into flexible devices to enable 3D or panoramic imaging by bending the device. This innovation could extend to phones, wearables, and laptops, showcasing Apple's ongoing research in enhancing device functionality and user experience.

Portfolio Pulse from Rounak Jain

March 13, 2024 | 1:38 pm

GAN

GAN (NASDAQ:GAN) reported Q4 earnings with a significant miss on estimated earnings by -40.0%, posting an EPS of $-0.21 against an estimate of $-0.15. Revenue also saw a decrease of $6.23 million from the same period last year. This follows a pattern of fluctuating performance in previous quarters, with the last quarter showing a beat on EPS estimates but no subsequent increase in share price.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 1:35 pm

TRDA

Entrada Therapeutics (NASDAQ:TRDA) reported Q4 earnings with a significant miss on estimated earnings by -71.0%, posting an EPS of $-0.29 against an estimate of $-0.17. However, revenue saw an increase of $41.85 million from the same period last year. Despite beating EPS estimates last quarter, the share price dropped by 1.0% the following day.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 1:35 pm

HPH

Puyi Inc. has officially changed its name to Highest Performances Holdings Inc., along with its ticker symbol from 'PUYI' to 'HPH'. The change follows shareholder approval of several resolutions, including amending the company's authorized share capital and exempting the company from holding an annual general meeting. The new structure includes 1,950,000,000 Ordinary Shares and 50,000,000 Preference Shares, with each Preference Share granting twenty votes.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 1:34 pm

SOS

Shares of SOS were halted due to a circuit breaker trigger after the stock plummeted by 20.7%.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 1:32 pm

DG

Dollar General Corp (NYSE:DG) is set to report its Q4 earnings on March 14, with Wall Street expecting $1.75 EPS and $9.78 billion in revenues. The stock has seen a significant recovery, up 55% since Oct. 2, 2023, and about 19% in 2024 so far. A Golden Cross is about to be triggered, indicating a bullish trend reversal. Analyst consensus rates the stock as Neutral with a price target of $134.07, though recent reviews suggest a target of $155-$158. The stock closed at $161.22 on March 12.

Portfolio Pulse from Surbhi Jain

March 13, 2024 | 1:30 pm